Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura

Marshall A. Mazepa, Jay S. Raval, Stephan Moll, Alice Ma, Yara A. Park

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)900-902
Number of pages3
JournalBritish Journal of Haematology
Volume164
Issue number6
DOIs
StatePublished - Mar 1 2014

Keywords

  • Bortezomib
  • Thrombotic haemolytic anaemias
  • Thrombotic thrombocytopenic purpura

Cite this